Risk factors and mortality of healthcare-associated and community-acquired Staphylococcus aureus bacteraemia

被引:105
作者
Bassetti, M. [1 ,2 ]
Trecarichi, E. M. [3 ]
Mesini, A. [1 ,2 ]
Spanu, T. [4 ]
Giacobbe, D. R. [1 ,2 ]
Rossi, M. [3 ]
Shenone, E. [1 ,2 ]
Pascale, G. D. [3 ]
Molinari, M. P. [5 ]
Cauda, R. [3 ]
Viscoli, C. [1 ,2 ]
Tumbarello, M. [3 ]
机构
[1] San Martino Hosp, Div Infect Dis, Genoa, Italy
[2] Univ Genoa, Sch Med, Genoa, Italy
[3] Univ Cattolica Sacro Cuore, Inst Infect Dis, I-00168 Rome, Italy
[4] Univ Cattolica Sacro Cuore, Inst Microbiol, I-00168 Rome, Italy
[5] San Martino Hosp, Lab Unit, Genoa, Italy
关键词
Healthcare-associated; methicillin-resistance; mortality; Staphylococcus aureus; METHICILLIN-RESISTANT; HOSPITAL MORTALITY; CLINICAL IMPACT; INFECTIONS; OUTCOMES; EPIDEMIOLOGY;
D O I
10.1111/j.1469-0691.2011.03679.x
中图分类号
R51 [传染病];
学科分类号
100201 [内科学];
摘要
Clin Microbiol Infect 2012; 18: 862869 Abstract Staphylococcus aureus bacteraemia (SAB) is a leading cause of mortality and morbidity in both nosocomial and community settings. The objective of the study is to explore epidemiological characteristics and predisposing risk factors associated with healthcare-associated (HCA) and community-acquired (CA) SAB, and to evaluate any differences in mortality and efficacy of initial antimicrobial therapy on treatment outcome. We conducted a two-part analysis. First, a triple casecontrol study in which groups of HCA SAB with onset =48 h after hospital admission (HCA =48 h), HCA SAB with onset <48 h of hospital admission (HCA <48 h), and CA SAB were compared with controls. Second, a cohort study including all patients with SAB was performed to identify factors associated with in-hospital mortality. SAB was diagnosed in 165 patients over the study period (January 2007 to December 2007). Five variables were independently associated with HCA =48 h SAB: presence of central venous catheter, solid tumour, chronic renal failure, previous hospitalization and previous antibiotic therapy. Significant risk factors for HCA <48 h SAB were: Charlson Comorbidity Index =3, previous hospitalization, living in long-term care facilities and corticosteroid therapy. Factors independently associated with CA SAB were: diabetes mellitus, HIV infection and chronic live disease. Patients with HCA <48 h SAB were significantly more likely to receive initial inadequate antimicrobial treatment than patients with CA or HCA =48 h SAB (44.8% versus 33.3% and 31.5%, respectively). Logistic-regression analysis identified three variables as independent predictors of mortality: presentation with septic shock, infection with methicillin-resistant S. aureus, and initial inadequate antimicrobial treatment. More than half of patients with SAB have MRSA strains and presentation with septic shock, and inappropriate empirical therapy was associated with increased mortality.
引用
收藏
页码:862 / 869
页数:8
相关论文
共 31 条
[1]
Increasing incidence but decreasing in-hospital mortality of adult Staphylococcus aureus bacteraemia between 1981 and 2000 [J].
Benfield, T. ;
Espersen, F. ;
Frimodt-Moller, N. ;
Jensen, A. G. ;
Larsen, A. R. ;
Pallesen, L. V. ;
Skov, R. ;
Westh, H. ;
Skinhoj, P. .
CLINICAL MICROBIOLOGY AND INFECTION, 2007, 13 (03) :257-263
[2]
A prospective multicenter study of Staphylococcus aureus bacteremia -: Incidence of endocarditis, risk factors for mortality, and clinical impact of methicillin resistance [J].
Chang, FY ;
MacDonald, BB ;
Peacock, JE ;
Musher, DM ;
Triplett, P ;
Mylotte, JM ;
O'Donnell, A ;
Wagener, MM ;
Yu, VL .
MEDICINE, 2003, 82 (05) :322-332
[3]
A NEW METHOD OF CLASSIFYING PROGNOSTIC CO-MORBIDITY IN LONGITUDINAL-STUDIES - DEVELOPMENT AND VALIDATION [J].
CHARLSON, ME ;
POMPEI, P ;
ALES, KL ;
MACKENZIE, CR .
JOURNAL OF CHRONIC DISEASES, 1987, 40 (05) :373-383
[4]
Clinical and Laboratory Standards Institute, 2009, METH DIL ANT SUSC TE
[5]
Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia:: A meta-analysis [J].
Cosgrove, SE ;
Sakoulas, G ;
Perencevich, EN ;
Schwaber, MJ ;
Karchmer, AW ;
Carmeli, Y .
CLINICAL INFECTIOUS DISEASES, 2003, 36 (01) :53-59
[6]
The impact of methicillin-resistance in Staphylococcus aureus bacteremia on patient outcomes:: Mortality, length of stay, and hospital charges [J].
Cosgrove, SE ;
Qi, YL ;
Kaye, KS ;
Harbarth, S ;
Karchmer, AW ;
Carmeli, Y .
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2005, 26 (02) :166-174
[7]
Clinical Impact of Antimicrobial Resistance in European Hospitals: Excess Mortality and Length of Hospital Stay Related to Methicillin-Resistant Staphylococcus aureus Bloodstream Infections [J].
de Kraker, Marlieke E. A. ;
Wolkewitz, Martin ;
Davey, Peter G. ;
Grundmann, Hajo .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2011, 55 (04) :1598-1605
[8]
European Antimicrobial Resistance Surveillance Network (EARS-Net), 2008, EARSS ANN REP 2008
[9]
[European Centre for Disease Prevention Control (ECDC) network], HEALTHC ASS INF
[10]
Long-term outcome and quality of care of patients with Staphylococcus aureus bacteremia [J].
Fätkenheuer, G ;
Preuss, M ;
Salzberger, B ;
Schmeisser, N ;
Cornely, OA ;
Wisplinghoff, H ;
Seifert, H .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2004, 23 (03) :157-162